Newsroom

Search

• 2017201620152014

Subscribe to E-mail Alerts

INC Research Continues Focus on Growth and Delivery in Japan	26 June 2017Yakuji Nippo Journal, Japan
Countdown to ICH E6 (R2) Implementation	23 June 2017Clinical Researcher
How to prepare for ICH E6 R2 Implementation	22 June 2017Outsourcing Pharma
Oncology: A Bouquet of Rare and Ultra-Rare Diseases	01 June 2017Journal for Clinical Studies
Seeing the Potential in M-Health	31 May 2017PharmaVOICE
Envisioning the site of the future	22 May 2017CenterWatch Monthly
Preparing for the ICH E6 Revisions	22 May 2017CenterWatch Monthly
Shift focus to rheumatoid arthritis subjects	22 May 2017CenterWatch Monthly
CROs and Next-Gen Drug Development	09 May 2017ContactPharma
The Rewards of Engaging Patients in Clinical Development and Beyond	17 April 2017SCRS Insite
Clinical Trials: Realising the Untapped Potential	12 April 2017pharmaphorum.com
Parexel brings a new patient sensor platform to market	10 April 2017CenterWatch Weekly
PSI, INC, Chiltern take top site ratings	06 April 2017CenterWatch Montly
Triangle CROs among best to work with, says survey	03 April 2017Triangle Business Journal
Trends in Protocol Development	22 March 2017PharmaVoice
Deep Dive: Patient Centric Trials – Dream or Reality?	06 March 2017PharmaPhorum.com
Extended and expanded: INC Research and Medidata enter into new tech partnership	03 March 2017Fierce Biotech
INC Research Expands FSP Services	27 February 2017Outsourcing-Pharma.com
The Outsourcing Big Picture	10 February 2017PharmaVoice
C-Suite Outlook: Leading Through Extraordinary Change	10 February 2017PharmaVoice
Reassessing Site Engagement Activities	01 February 2017CenterWatch
Personalized medicine impacting study conduct	31 January 2017CenterWatch
Integrative Approach to the Conduct of Rare Disease Clinical Trials	31 January 2017Journal of Clinical Sciences
Why would Cardiovascular Outcomes Trials and Rare Disease Studies have Anything in Common?	31 January 2017Journal of Clinical Sciences
Inspiring Hope Ideathon E-Book	09 January 2017PharmaVOICE
Focus on Rare Diseases	04 January 2017PharmaVOICE